ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-3

  1. 26 Posts.
    So am I right in assuming that they don't have market authorization as of yet (approval for sale).

    What is the next step that has to happen for them to get approval for sale.

    Regards
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $45.28K 15.09M

Buyers (Bids)

No. Vol. Price($)
58 101407102 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 17448796 5
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.